Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer

  Free Subscription


23.09.2019

1 Biochem Biophys Res Commun
1 Biomolecules
1 BMJ Sex Reprod Health
1 Br J Cancer
1 Cancer Epidemiol
1 Cancer Manag Res
1 Clin Microbiol Infect
3 Eur Rev Med Pharmacol Sci
1 Healthcare (Basel)
1 Int J Nanomedicine
1 J Med Virol
1 Obstet Gynecol Sci
2 Oncol Res Treat
1 PLoS One
1 Sci Rep
1 Technol Cancer Res Treat


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. ZHU L, Yu CL, Zheng Y
    NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-beta/TGF-betaRI/SMADs signaling.
    Biochem Biophys Res Commun. 2019 Sep 14. pii: S0006-291X(19)31522.
    PubMed     Text format     Abstract available


    Biomolecules

  2. KHUMKHRONG P, Piboonprai K, Chaichompoo W, Pimtong W, et al
    Crinamine Induces Apoptosis and Inhibits Proliferation, Migration, and Angiogenesis in Cervical Cancer SiHa Cells.
    Biomolecules. 2019;9.
    PubMed     Text format     Abstract available


    BMJ Sex Reprod Health

  3. JORGENSEN L, Gotzsche PC, Jefferson T
    Increased incidence of cervical cancer in Sweden: an unlikely link with human papillomavirus (HPV) vaccination.
    BMJ Sex Reprod Health. 2019 Sep 18. pii: bmjsrh-2018-200245.
    PubMed     Text format    


    Br J Cancer

  4. GILBERT DC, Wakeham K, Langley RE, Vale CL, et al
    Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
    Br J Cancer. 2018 Nov 28. pii: 10.1038/s41416-018-0273.
    PubMed     Text format     Abstract available


    Cancer Epidemiol

  5. SRIPAN P, Chitapanarux I, Fidler-Benaoudia MM, Miranda-Filho A, et al
    Impact of universal health care and screening on incidence and survival of Thai women with cervical cancer: A population-based study of the Chiang Mai Province.
    Cancer Epidemiol. 2019;63:101594.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  6. ZHAO J, Guo Z, Wang Q, Si T, et al
    HPV infection associated DNA damage correlated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China.
    Cancer Manag Res. 2019;11:7197-7210.
    PubMed     Text format     Abstract available


    Clin Microbiol Infect

  7. MAVER PJ, Poljak M
    Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
    Clin Microbiol Infect. 2019 Sep 17. pii: S1198-743X(19)30491.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  8. WEI YQ, Jiao XL, Zhang SY, Xu Y, et al
    MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
    Eur Rev Med Pharmacol Sci. 2019;23:7314-7326.
    PubMed     Text format     Abstract available

  9. TIAN Y, Wang YR, Jia SH
    Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS.
    Eur Rev Med Pharmacol Sci. 2019;23:7307-7313.
    PubMed     Text format     Abstract available

  10. ZHAO H, Hu GM, Wang WL, Wang ZH, et al
    LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression.
    Eur Rev Med Pharmacol Sci. 2019;23:7295-7306.
    PubMed     Text format     Abstract available


    Healthcare (Basel)

  11. KAGABU M, Nagasawa T, Fukagawa D, Tomabechi H, et al
    Immunotherapy for Uterine Cervical Cancer.
    Healthcare (Basel). 2019;7.
    PubMed     Text format     Abstract available


    Int J Nanomedicine


  12. Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models [Corrigendum].
    Int J Nanomedicine. 2019;14:6133.
    PubMed     Text format    


    J Med Virol

  13. XU H, Yu Y, George W, Smith JS, et al
    Comparison of the performance of paired urine and cervical samples for cervical cancer screening in screening population.
    J Med Virol. 2019 Sep 19. doi: 10.1002/jmv.25597.
    PubMed     Text format     Abstract available


    Obstet Gynecol Sci

  14. LIU H, Lee G, Lee JI, Ahn TG, et al
    Effects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell lines.
    Obstet Gynecol Sci. 2019;62:322-328.
    PubMed     Text format     Abstract available


    Oncol Res Treat

  15. LEETANAPORN K, Hanprasertpong J
    Impact of Obesity on Clinical Outcomes in Patients with Early-Stage Cervical Cancer after Radical Hysterectomy with Pelvic Node Dissection.
    Oncol Res Treat. 2019 Sep 18:1-8. doi: 10.1159/000502752.
    PubMed     Text format     Abstract available

  16. DELIA P, Sansotta G, Pontoriero A, Iati G, et al
    Clinical Evaluation of Low-Molecular-Weight Hyaluronic Acid-Based Treatment on Onset of Acute Side Effects in Women Receiving Adjuvant Radiotherapy after Cervical Surgery: A Randomized Clinical Trial.
    Oncol Res Treat. 2019;42:217-223.
    PubMed     Text format     Abstract available


    PLoS One

  17. PAGE CM, Ibrahim S, Park LP, Huchko MJ, et al
    Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study.
    PLoS One. 2019;14:e0222750.
    PubMed     Text format     Abstract available


    Sci Rep

  18. KIM BH, Chang JH
    Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancer.
    Sci Rep. 2019;9:13301.
    PubMed     Text format     Abstract available


    Technol Cancer Res Treat

  19. LIU C, Wang X, Zhang Y
    The Roles of HK2 on Tumorigenesis of Cervical Cancer.
    Technol Cancer Res Treat. 2019;18:1533033819871306.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: